USSTOCK.TODAY
Market Closed
Log in Sign up

Illumina, Tempus AI, and Novartis Raise FY2026 Guidance

Zacks · ·by G4L

NVS Novartis AG ADR
$163.26 -0.26%
View chart & analysis →
ILMN -2.66%TEM TEM -4.62%
  1. 1Illumina recorded Q3 quarterly revenue of $1.13 billion.
  2. 2Tempus AI achieved revenue of $411.5 million, a 23% increase year-over-year.
  3. 3Novartis raised its FY2026 core operating income outlook from flat to low single-digit growth.

So what's the key point?

Illumina and Tempus AI saw revenue growth, while Novartis raised its profit outlook. These companies are expected to see improved performance.

Source Zacks · View original ↗

Related 3-line summaries

Novartis Discontinues Development of Cardiovascular Treatment Pelacarsen Investing.com · 2d agoTempus AI beats expectations with $411.5 million in Q3 revenue Associated Press · Nov 2Deutsche Bank Downgrades Novartis Rating and Adjusts Price Target Investing.com · Nov 2
Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →
← Back to news